Former White House Drug Czar Warns Congress: Fragile Overdose Declines Risk Reversal Without $10B Modernization Plan
Cover of Inside America’s Opioid Crisis: 12 Hard Lessons for Today’s Drug War, examining federal drug policy in the synthetic fentanyl era.
Calls Current Federal Drug Strategy “Outdated for the Synthetic Era”
If Congress treats recent overdose declines as a victory, we risk repeating the mistakes of the past decade”
WASHINGTON, DC, UNITED STATES, February 19, 2026 /EINPresswire.com/ -- National overdose deaths have declined for the first time in years. But that progress is fragile and could reverse without structural reform and sustained federal investment, according to Richard J. Baum, former Acting Director of the White House Office of National Drug Control Policy.— Richard J. Baum
In his new book, released today, Inside America’s Opioid Crisis: 12 Hard Lessons for Today’s Drug War (Bloomsbury Academic, February 19), Baum argues that the United States is confronting a synthetic drug epidemic with systems designed for an earlier era of heroin and prescription opioids.
“The threat modernized,” Baum said. “But we did not modernize the response. If Congress treats recent overdose declines as a victory, we risk repeating the mistakes of the past decade.”
More than one million Americans have died from drug overdoses since the late 1990s. While overdoses have declined recently, Baum warns that tens of millions of Americans continue to struggle with substance use disorders — many involving complex polysubstance addiction that combines fentanyl, methamphetamine, and cocaine.
“These are not short-term treatment challenges,” Baum said. “Many individuals require sustained engagement, often a year or more, along with extended recovery support. Our systems were not built for this reality.”
Baum is urging Congress to enact a sustained $10 billion annual modernization initiative — approximately a 20 percent increase over the nearly $50 billion already annually on national drug control efforts — to align federal strategy with the scale and complexity of today’s synthetic drug market.
“This is not a spending revolution,” Baum said. “It is a structural course correction. We are already spending billions downstream — on emergency care, incarceration, foster care, Medicaid, lost productivity, and drug-related crime. A modest upstream increase would stabilize treatment access, strengthen recovery systems, and modernize enforcement.”
Drawing on 28 years at the White House Office of National Drug Control Policy across six presidential administrations — including service as Acting Director (2017–2018) and Executive Director of the President’s Opioid Commission — Baum outlines twelve “hard lessons” and 32 structural reforms focused on:
• Expanding voluntary pathways into sustained treatment
• Building nationwide recovery-support infrastructure
• Strengthening collaboration between courts, jails, law enforcement, and treatment providers
• Modernizing retail drug enforcement without returning to mass incarceration
• Updating border and precursor control strategies for synthetic supply chains
“Congress faces a choice,” Baum said. “Apply the lessons of the past fifteen years — or leave the nation unprepared for the next phase of this crisis.”
Inside America’s Opioid Crisis: 12 Hard Lessons for Today’s Drug War is available today on Amazon. A free companion 17-part public education video series is available at www.RichardJBaum.com.
Media Contact:
Richard J. Baum
media@richardjbaum.com
(202) 743-2746
Baum is available for interviews.
________________________________________
About Richard J. Baum
Richard J. Baum served for 28 years at the White House Office of National Drug Control Policy across six presidential administrations, including as Acting Director (2017–2018) and Executive Director of the President’s Opioid Commission. He is currently an adjunct professor at Georgetown University, focusing on drug policy reform and public education.
Richard J Baum
Author, Georgetown Professor, Drug Policy Advisor
+1 202-743-2746
email us here
Visit us on social media:
LinkedIn
YouTube
Inside America’s Opioid Crisis: Author Overview by Richard J. Baum
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
